This is the authors' abstract. We don't add key points for this paper.
Sexually transmitted infection rates continue to rise in adolescents and young adults. Treatment of patients and their partners is vitally important to prevent reinfection and morbidity. Expedited partner therapy (EPT) is a legally available option for clinicians. EPT is endorsed by the Centers for Disease Control and Prevention and allows clinicians to prescribe medication for certain STIs for their patients' partner(s) without an evaluation of the partner(s). However, EPT is underutilized, and multisystem-level barriers exist to successful EPT exist. This article reviews the indications of EPT, common barriers to EPT and solutions to overcome these barriers, and practical considerations when prescribing EPT.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Michelle L. Pickett (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: